OTC Pharmaceuticals & Pharmacy Retailing in China 2010: A Market Analysis


July 9, 2010
125 Pages - SKU: ACS2735071
License type:
Table of Contents Search inside this report Related Reports
Countries covered: China

This new report covers the retail market for western drugs, traditional Chinese medicines, vitamins, minerals & supplements, and other pharmaceutical products sold through the retail channel in China, and the drugstore market.

KEY REPORT FEATURES

This new report includes:
  • Total and sectoral retail sales of OTC pharmaceuticals to 2009.
  • Pharmacy retail industry network and sales data to 2009.
  • Ranking of leading drugs producers by sector to 2009.
  • Prices on selected pharmaceuticals products 2010.
  • Forecast sectoral and total sales of OTC pharmaceuticals to 2014.
  • Imports and exports of OTC pharmaceuticals to 2009.
  • Size of the pharmacy market by store numbers to 2009.
  • Ranking of the Top-25 pharmacies in China to 2009.
  • Market forecasts to 2014.
  • Current issues including latest six financial quarters’ key retailer developments.
  • Key background consumer market data to 2009.
  • Profiles of 15 of the leading pharmacy retailers and drugs manufacturers in China, with financial and network data to 2009.
  • Key demographic data, including detailed age group and by habitation and province.


Additional Information

Executive Summary

China has a large and fast-growing OTC pharmaceuticals industry. The total OTC pharmaceuticals retail market increased to RMB72.02bn in 2009, and the market is expected to surpass RMB100bn by 2013. Retail sales value of OTC drugs expanded by 102% between 2003 and 2009.

Increasing public awareness about health care and the importance of self-medication as well as the rapid rise in urban living standards and growing disposable income levels are combining to allow for the increased purchase of OTC pharmaceuticals and consequently propelling growth in the market.

China’s USD 124bn healthcare reform, announced in April 2009, will boost demand for pharmaceutical products ranging from generic drugs to medical equipment. The long-term implication of the healthcare reform on the OTC pharmaceuticals retail market and the pharmacy retailing market is still too early to tell.

However, anecdotal evidence has suggested a 40-60% decline in store traffic in some of the drugstores located in places that have implemented the healthcare reform. As part of the healthcare reform, essential drugs are to be sold at government hospitals at wholesale prices.

Drugstores will benefit immensely from the healthcare reform only when there is a clear separation of drug dispensing and prescribing. In the meantime, drugstores are looking at ways to improve their thinning margins. Some have turned to the internet and some to private label. Most of them are now selling other non-pharmaceutical products such as personal care, family care and convenience products.

The weakness of retail prices, caused by intense competition, continues to put pressure on retailer’s margins, forcing them to consolidate further.

Consolidation is being hampered by the low barrier of entry into this sector. As it is easy for new entrants to come into the market, the country is seeing an oversupply of drugstores. In Guangzhou alone, there is one drugstore for every 1,500 people. As the market share of the top 10 drugstore chains remains low, no chains will be dominating the pharmacy market for the foreseeable future.

In 2009, the drugs retail market stood at RMB136bn, up 119% over 2003. The drugs retail market is expected to grow by 56% in constant value terms between 2010 and 2015.
INTRODUCTION
Report Coverage
Abbreviations Used
Other Relevant Reports from Access Asia
China Retail Quarterly
1 CHINA¡¯S OTC DRUGS & PHARMACY RETAILING MARKET
1.1 Overview
1.2 China¡¯s Total Non-Food Market
1.2.1 Total Non-Food Market: Food & Non-Food Sales
Table 1.1 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD, 2003-2009
1.2.2 Total Non-Food Market: Food/Non-Food Sales Split
Table 1.2 % BREAKDOWN OF SALES BY FOOD AND NON-FOOD, 2003-2009
1.2.3 Total Non-Food Market: Urban/Rural Split
Table 1.3 TOTAL CURRENT VALUE RETAIL SALES BY FOOD & NON-FOOD, 2003-2009
1.2.4 Total Non-Food Market: The Trends
Table 1.4 CURRENT VALUE OF TOTAL RETAIL NON-FOOD SALES BY MAJOR PRODUCT CATEGORY, 2003-2009
1.3 China¡¯s OTC Pharmaceuticals Market
1.3.1 OTC Pharmaceuticals Market: Overview
1.3.2 OTC Pharmaceuticals Market: Total Market Size
Figure 1.1: Total OTC Pharmaceuticals Retail Sales Growth, 2003-2009
Table 1.5 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009
1.3.3 OTC Pharmaceuticals Market: Total Market Growth
Table 1.6 % ANNUAL GROWTH OF THE TOTAL OTC PHARMACEUTICALS RETAIL MARKET IN CHINA, 2003-2009
1.3.4 OTC Pharmaceuticals Market: Per Capita Consumption
Table 1.7 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009
1.3.5 OTC Pharmaceuticals Market: Non-Food Market Significance
Table 1.8 OTC PHARMACEUTICAL SALES AS A PROPORTION OF TOTAL NON-FOOD EXPENDITURE IN CHINA, 2003-2009
1.4 Sector Breakdown
1.4.1 Retail Sector Breakdown: Sector Values
Figure 1.2: Total OTC Pharmaceutical Retail Market Value Sales Growth, 2003-2009
Table 1.9 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009
1.4.2 Retail Sector Breakdown: Sector Shares
Table 1.10 % BREAKDOWN OF THE TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009
1.4.3 Retail Sector Breakdown: Annual Growth Rates
Table 1.11 % ANNUAL GROWTH OF THE RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT VALUE TERMS IN CHINA, 2003-2009
1.5 Market Shares
1.5.1 Market Shares: Ranking of Leading Western OTC Drugs
Table 1.12 RANKING OF LEADING WESTERN OTC DRUGS IN CHINA, 2009
1.5.2 Market Shares: Ranking of Leading Traditional Chinese Medicine OTC Drugs
Table 1.13 RANKING OF LEADING TRADITIONAL CHINESE MEDICINE OTC DRUGS IN CHINA, 2009
1.5.3 Ranking: Top 20 OTC Pharmaceutical Manufacturers
Table 1.14 TOP 20 OTC PHARMACEUTICAL MANUFACTURERS IN CHINA, 2009
1.5.4 Market Shares: Children¡¯s OTC Drugs
Table 1.15 MARKET SHARE OF TOP CHILDREN¡¯S OTC DRUGS IN CHINA, 2007-2009
1.5.5 Market Shares: Cold Medicines
Table 1.16 MARKET SHARE OF TOP COLD MEDICINES IN CHINA, 2006
1.5.6 Market Shares: TCM Antipyretic Granules
Table 1.17 MARKET SHARE OF TOP TCM ANTIPYRETIC GRANULES IN CHINA, 2008
1.5.7 Market Shares: Pharyngeal & Laryngeal Medicines
Table 1.18 MARKET SHARE OF TOP PHARYNGEAL & LARYNGEAL MEDICINES IN CHINA, 2008
1.5.8 Market Shares: External Analgesic
Table 1.19 MARKET SHARE OF TOP EXTERNAL ANALGESICS IN CHINA, 2008
1.5.9 Market Shares: Dermatological
Table 1.20 MARKET SHARE OF TOP DERMATOLOGICAL MANUFACTURERS IN CHINA, 2005-2007
1.5.10 Market Shares: Gastrointestinal
Table 1.21 MARKET SHARE OF TOP GASTROINTESTINAL DRUGS IN CHINA, 2007
Table 1.22 MARKET SHARE OF TOP TRADITIONAL CHINESE MEDICINE GASTROINTESTINAL DRUGS IN CHINA, 2007
1.5.11 Market Shares: Anti-Allergy
Table 1.23 MARKET SHARE OF TOP ANTI-ALLERGY DRUGS BY CITIES IN CHINA, 2007-2009
1.5.12 Market Shares: Vitamin
Table 1.24 MARKET SHARE OF TOP VITAMIN MANUFACTURERS BY CITIES, 2007¨C1H2009
1.6 Prices
1.6.1 Prices: Retail Price Indices
Table 1.25 AVERAGE INCOME ANNUAL GROWTH BY SECTOR, 2005-2008
Table 1.26 RETAIL PRICE INDICES BY BROAD SECTOR, 2000-2009
1.6.2 Prices: Selected Product Prices
Table 1.27 RETAIL PRICES OF SELECTED WESTERN ANTI-ALLERGY DRUGS, JUNE 2010
Table 1.28 RETAIL PRICES OF SELECTED EYE DROPS, JUNE 2010
Table 1.29 RETAIL PRICES OF SELECTED WESTERN ANTIPYRETIC, ANALGESIC, ANTI-INFLAMMATORY & COLD MEDICINES, JUNE 2010
Table 1.30 RETAIL PRICES OF SELECTED WESTERN RESPIRATORY DRUGS, JUNE 2010
Table 1.31 RETAIL PRICES OF SELECTED WESTERN EAR, NOSE & THROAT MEDICINES, JUNE 2010
Table 1.32 RETAIL PRICES OF SELECTED VITAMINS & SUPPLEMENTS, JUNE 2010
Table 1.33 RETAIL PRICES OF SELECTED WESTERN DERMATOLOGICAL MEDICINES, JUNE 2010
Table 1.34 RETAIL PRICES OF SELECTED WESTERN GASTROINTESTINAL MEDICINES, JUNE 2010
Table 1.35 RETAIL PRICES OF SELECTED TCM COLD MEDICINES, JUNE 2010
Table 1.36 RETAIL PRICES OF SELECTED TCM GASTROINTESTINAL MEDICINES, JUNE 2010
Table 1.37 RETAIL PRICES OF SELECTED TCM THROAT MEDICINES, JUNE 2010
Table 1.38 RETAIL PRICES OF SELECTED TCM HEAT CLEARING & DETOXICATING REMEDIES, JUNE 2010
Table 1.39 RETAIL PRICES OF SELECTED TCM RESPIRATORY MEDICINES, JUNE 2010
Table 1.40 RETAIL PRICES OF SELECTED TCM ORTHOPEDIC MEDICINES, JUNE 2010
1.7 Outlook
1.7.1 Outlook: Forecast Trends
1.7.2 Outlook: Total OTC Pharmaceuticals Retail Market Size
Table 1.41 FORECAST TOTAL VALUE MARKET FOR OTC PHARMACEUTICALS IN CHINA, 2010-2015
1.7.3 Outlook: Total Retail Sector Values
Figure 1.3: Forecast OTC Pharmaceuticals Value Sales Growth by Sector, 2010-2015
Table 1.42 FORECAST CONSTANT 2009 VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015
1.7.4 Outlook: Total Retail Sector Breakdown
Table 1.43 FORECAST % VALUE SALES BREAKDOWN OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015
1.7.5 Outlook: Total Retail Sector Growth
Table 1.44 FORECAST ANNUAL % VALUE SALES GROWTH OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015
1.8 Pharmaceutical Products Import & Export Volume
Table 1.45 HS CODE DESCRIPTION
1.8.1 Pharmaceutical Products Import & Export Volume: Total Trade Volume
Table 1.46 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT VOLUME & GROWTH, 2000-2009
1.8.2 Pharmaceutical Products Import & Export Volume: Import Volume
Table 1.47 VOLUME BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009
1.8.3 Pharmaceutical Products Import & Export Volume: Export Volume
Table 1.48 VOLUME BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009
1.9 Pharmaceutical Products Import & Export Value
1.9.1 Pharmaceutical Products Import & Export Value: Total Trade Value
Table 1.49 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT VALUE & GROWTH, 2000-2009
1.9.2 Pharmaceutical Products Import & Export Value: Import Value
Table 1.50 VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009
1.9.3 Pharmaceutical Products Import & Export Value: Export Value
Table 1.51 VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009
1.10 Pharmaceutical Products Import & Export Average Unit Value
1.10.1 Pharmaceutical Products Import & Export Average Unit Value: Overview
Table 1.52 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT AVERAGE UNIT VALUE & GROWTH, 2000-2009
1.10.2 Pharmaceutical Products Import & Export Average Unit Value: Import
Table 1.53 AVERAGE UNIT VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009
1.10.3 Pharmaceutical Products Import & Export Average Unit Value: Export
Table 1.54 AVERAGE UNIT VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009
2 PHARMACY RETAILING
2.1 China¡¯s Drugs Retail Market
2.1.1 Drugs Retail Market: Total Market Size
Figure 2.1: Total Drugs Retail Market Sales Growth, 2003-2009
Table 2.1 TOTAL DRUGS RETAIL MARKET IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009
2.1.2 Drugs Retail Market: Total Market Growth
Table 2.2 % ANNUAL GROWTH OF THE TOTAL DRUGS RETAIL MARKET IN CHINA, 2003-2009
2.1.3 Drugs Retail Market: Medical and Healthcare significance
Table 2.3 DRUGS RETAIL SALES AS A PROPORTION OF TOTAL MEDICAL & HEALTHCARE EXPENDITURE IN CHINA, 2003-2009
2.2 Sector Breakdown
2.2.1 Sector Breakdown: Sector Sizes
Figure 2.2: Total Drugs Retail Market Value Sales Growth, 2003-2009
Table 2.4 TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009
2.2.2 Sector Breakdown: Sector Shares
Table 2.5 % BREAKDOWN OF THE TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009
2.2.3 Sector Breakdown: Sector Growth
Table 2.6 % ANNUAL GROWTH OF THE TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009
2.3 Pharmacy Market
2.3.1 Pharmacy Market: Number of Stores
Table 2.7 CHINA PHARMACY RETAIL OUTLETS BY OWNERSHIP STRUCTURE, 2006-2008
2.3.2 Pharmacy Market: Top 100 Pharmacy Chains
Table 2.8 PHARMACY RETAIL SALES BY THE TOP-100, -50, -30 % -10 PHARMACY CHAINS IN CHINA, 2003-2009
2.3.3 Pharmacy Market: Market Shares
Table 2.9 TOP 10 PHARMACY RETAIL CHAINS % SHARE OF DRUGSTORE SALES, 2003-2009
2.3.4 Pharmacy Market: Revenue of Top 25 Pharmacy Chains
Table 2.10 RANKING OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009
Table 2.11 REVENUE OF TOP 25 PHARMACIES IN CHINA, 2003-2009
2.3.5 Pharmacy Market: Revenue Growth of Top 25 Pharmacy Chains
Table 2.12 REVENUE GROWTH RATE OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009
2.3.6 Pharmacy Market: Store Network of Top 25 Pharmacy Chains by Revenue
Table 2.13 TOP STORE NETWORK OF 25 LEADING PHARMACIES BY REVENUE IN CHINA, 2003-2009
2.3.7 Pharmacy Market: Average Revenue Per Store of Top 25 Pharmacy Chains by Revenue
Table 2.14 AVERAGE REVENUER PER STORE OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009
2.3.8 Pharmacy Market: Top 20 Pharmacies by Number of Franchise Outlets
Table 2.15 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF FRANCHISE STORES, 2008
Table 2.16 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF FRANCHISE STORES, 2009
2.3.9 Pharmacy Market: Top 20Pharmacies by Number of Directly Operated Outlets
Table 2.17 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF DIRECTLY OPERATED STORES, 2008
Table 2.18 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF DIRECTLY OPERATED STORES, 2009
2.3.10 Pharmacy Market: Diversification
Table 2.19 SHARE OF NON-DRUGS IN PHARMACY RETAILING, 2009
2.3.11 Pharmacy Market: Internet Pharmacies
Table 2.20 GOVERNMENT-APPROVED ONLINE PHARMACIES, AS OF 16 JUNE 2010
Table 2.21 ILLEGAL DRUG SELLING WEBSITES IN CHINA, 2008-2010
2.3.12 Pharmacy Market: Profit Margins
Table 2.22 GROSS PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2006-2009
Table 2.23 GROSS PROFIT MARGINS OF SELECTED PHARMARCIES IN CHINA, 2009
Table 2.24 NET PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2006-2009
Table 2.25 TOP 10 PHARMACIES IN CHINA BY PRE-TAX PROFIT MARGINS, 2008
Table 2.26 TOP 10 PHARMACIES IN CHINA BY PRE-TAX PROFITS, 2009
Table 2.27 PRE-TAX PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2009
2.3.13 Pharmacy Market: Private Label
Table 2.28 SHARE OF PRIVATE LABEL OR HIGH MARGIN PRODUCTS OF DRUGSTORE CHAINS, 2009
Nepstar
Table 2.29 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: NUMBER OF PRIVATE LABEL PRODUCTS, 2006-2009*
Table 2.30 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: PRIVATE LABEL REVENUE SHARE, 2006-2009
Watsons
2.3.14 Pharmacy Market: Health & Beauty Chain Developments
Table 2.31 MANNINGS STORES IN CHINA, 2003-2009
Table 2.32 WATSONS STORES IN CHINA
2.3.15 Pharmacy Market: Mergers & Acquisitions
Table 2.33 SELECTED MERGERS & ACQUISITIONS IN CHINA, 2009-JUNE 2010
2.4 Outlook
2.4.1 Outlook: Forecast Trends
2.4.2 Outlook: Total Drugs Retail Market Size
Table 2.34 FORECAST TOTAL VALUE FOR DRUGS RETAIL MARKET IN CHINA, 2010-2015
2.4.3 Outlook: Total Drugs Retail Sector Values
Figure 2.3: Forecast Drugs Retail Value Sales Growth by Sector, 2010-2015
Table 2.35 FORECAST CONSTANT 2009 VALUE SALES OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015
2.4.4 Outlook: Total Drugs Retail Sector Breakdown
Table 2.36 FORECAST % VALUE SALES BREAKDOWN OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015
2.4.5 Outlook: Total Drugs Retail Sector Growth
Table 2.37 FORECAST ANNUAL % VALUE SALES GROWTH OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015
3 COMPANY PROFILES
OTC Pharmaceutical Manufacturers
3.1 BMP Sunstone Corp.
3.1.1 BMP Sunstone: Company Details
3.1.2 BMP Sunstone: Company Background
Table 3.1 BMP SUNSTONE CORP.: % BREAKDOWN OF NET REVENUE BY PRODUCT SEGMENT, 2008-2009
Table 3.2 BMP SUNSTONE CORP.: REVENUE BY BUSINESS, 2006-2009
3.1.3 BMP Sunstone: Financial Results
Table 3.3 BMP SUNSTONE CORP.: FINANCIAL RESULTS, 2004-2009*
Table 3.4 BMP SUNSTONE CORP.: % BREAKDOWN OF TOTAL REVENUE, 2004-2009*
3.2 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
3.2.1 China Resources Sanjiu Medical & Pharmaceutical: Company Details
3.2.2 China Resources Sanjiu Medical & Pharmaceutical: Company Background
Table 3.5 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: BREAKDOWN OF MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2007-2009
3.2.2 China Resources Sanjiu Medical & Pharmaceutical: Financial Results
Table 3.6 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.7 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
3.3 Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.
3.3.1 Harbin Pharm. Group Sanjin Pharmaceutical: Company Details
3.3.2 Harbin Pharm. Group Sanjin Pharmaceutical: Company Background
Table 3.8 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2006-2009
Table 3.9 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL MARKET, 2006-2009*
3.3.3 Harbin Pharm. Group Sanjin Pharmaceutical: Financial Results
Table 3.10 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.11 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
3.4 Jiangzhong Pharmaceutical Co., Ltd.
3.4.1 Jiangzhong Pharmaceutical: Company Details
3.4.2 Jiangzhong Pharmaceutical: Company Background
Table 3.12 JIANGZHONG PHARMACEUTICAL CO., LTD.: REVENUES OF OTC PRODUCTS, 2005-2009
Table 3.13 JIANGZHONG PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2006-2009
Table 3.14 JIANGZHONG PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY GEOGRAPHICAL MARKET, 2006-2009
3.4.3 Jiangzhong Pharmaceutical: Financial Results
Table 3.15 JIANGZHONG PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.16 JIANGZHONG PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
3.4 Shandong Dong-E E-Jiao Co., Ltd.
3.5.1 Shandong Dong-E E-Jiao: Company Details
3.5.2 Shandong Dong-E E-Jiao: Company Background
Table 3.17 SHANDONG DONG-E E-JIAO CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2006-2007
Table 3.18 SHANDONG DONG-E E-JIAO CO., LTD.: MAIN OPERATING REVENUE BY PRODUCT SEGMENT, 2007-2009
3.5.3 Shandong Dong-E E-Jiao: Financial Results
Table 3.19 SHANDONG DONG-E E-JIAO CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.20 SHANDONG DONG-E E-JIAO CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
3.6 Sino-American Tianjin Smith Kline & French Laboratories Ltd. (TSKF)
3.6.1 Sino-American Tianjin Smith Kline & French Laboratories: Company Details
3.6.2 Sino-American Tianjin Smith Kline & French Laboratories: Company Background
Table 3.21 GLAXOSMITHKLINE (CHINA) INVESTMENT CO., LTD.: KEY OTC MEDICINES & CONSUMER HEALTHCARE PRODUCTS IN CHINA
3.6.3 Sino-American Tianjin Smith Kline & French Laboratories: Financial Results
Table 3.22 SINO-AMERICAN TIANJIN SMITH KLINE & FRENCH LABORATORIES LTD.: FINANCIAL RESULTS, 2002-2009*
3.7 Tibet Cheezheng Tibetan Medicine Co., Ltd.
3.7.1 Tibet Cheezheng Tibetan Medicine: Company Details
3.7.2 Tibet Cheezheng Tibetan Medicine: Company Background
Table 3.23 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: MAIN OPERATING REVENUE BY PRODUCT SEGMENT, 2006-2009
Table 3.24 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL REGION, 2006-2009*
3.7.3 Tibet Cheezheng Tibetan Medicine: Financial Results
Table 3.25 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.26 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
3.8 Yunnan Baiyao Group Co., Ltd.
3.8.1 Yunnan Baiyao Group: Company Details
3.8.2 Yunnan Baiyao Group: Company Background
Table 3.27 YUNNAN BAIYAO GROUP CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS, 2007-2009*
Table 3.28 YUNNAN BAIYAO GROUP CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL MARKET, 2007-2009*
3.8.3 Yunnan Baiyao Group: Financial Results
Table 3.29 YUNNAN BAIYAO GROUP CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.30 YUNNAN BAIYAO GROUP CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009*
Pharmaceutical Distributors and Retailers
3.9 China Nepstar Chain Drugstore Ltd.
3.9.1 China Neptar Chain Drugstore: Company Details
3.9.2 China Neptar Chain Drugstore: Company Background
Table 3.31 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: DETAILS ON STORE OPENING, CLOSURE & ACQUISITION, 2004-2009
Table 3.32 CHINA NEPSTAR DRUGSTORE LTD.: % BREAKDOWN OF OUTLET BY CITY, 2004-2009
Table 3.33 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: REVENUE BREAKDOWN BY PRODUCT CATEGORY, 2004-2009
Table 3.34 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: NUMBER OF PRIVATE LABEL PRODUCTS, 2006-2009*
Table 3.35 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: PRIVATE LABEL REVENUE SHARE, 2006-2009
Table 3.36 CHINA NEPSTAR DRUGSTORE LTD.: LOYALTY SCHEME MEMBERS, 2005-2009*
Table 3.37 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: YEARLY SAME STORE SALES, 2007-2009*
Table 3.38 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: QUARTERLY SAME STORE SALES, 2007-2009*
Table 3.39 CHINA NEPSTAR DRUGSTORE LTD.: NUMBER OF EMPLOYEES, 2004-2009
3.9.2 China Neptar Chain Drugstore: Financial Results
Table 3.40 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: FINANCIAL RESULTS, 2004-2009*
Table 3.41 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2004-2009*
3.10 Chongqing Tong Jun Ge Co., Ltd.
3.10.1 Chongqing Tong Jun Ge: Company Details
3.10.2 Chongqing Tong Jun Ge: Company Background
Table 3.42 CHONGQING TONG JUN GE CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009
Table 3.43 CHONGQING TONG JUN GE CO., LTD.: NET PROFIT OF KEY PHARMACEUTICAL RETAIL SUBSIDIARIES, 2004-2009
Table 3.44 CHONGQING TONG JUN GE DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009
Table 3.45 SICHUAN TIANCHENG DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009
Table 3.46 SICHUAN TAIJI DRUGSTORE CO., LTD.: NUMBER OF STORES, 2005-2009
3.10.3 Chongqing Tong Jun Ge: Financial Results
Table 3.47 CHONGQING TONG JUN GE DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009
Table 3.48 SICHUAN TIANCHENG DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009
Table 3.49 SICHUAN TAIJI DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2005-2009
Table 3.50 CHONGQING TONG JUN GE CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.51 CHONGQING TONG JUN GE CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009*
3.11 Liaoning Cheng Da Co., Ltd.
3.11.1 Liaoning Cheng Da: Company Details
3.11.2 Liaoning Cheng Da: Company Background
Table 3.52 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: STORE NETWORK, 2003-2009*
Table 3.53 LIAONING CHENG DA CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009
3.11.3 Liaoning Cheng Da: Financial Results
Table 3.54 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: FINANCIAL RESULTS, 2007-2009*
Table 3.55 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: FINANCIAL RESULTS, 2003-2009*
Table 3.56 LIAONING CHENG DA CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.57 LIAONING CHENG DA CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009*
3.12 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
3.12.1 Shanghai Fosun Pharmaceutical (Group): Company Details
3.12.2 Shanghai Fosun Pharmaceutical (Group): Company Background
Table 3.58 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009
Table 3.59 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: REVENUE & NET PROFIT OF KEY PHARMACEUTICAL RETAILING UNITS AND ASSOCIATES, 2006-2009
Table 3.60 SHANGHAI FUMEI YIXING DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009
Table 3.61 BEIJING GOLDEN ELEPHANT DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009
Table 3.62 SHANGHAI YAOFANG CO., LTD.: NUMBER OF STORES, 2003-2009
3.12.3 Shanghai Fosun Pharmaceutical (Group): Financial Results
Table 3.63 SHANGHAI FUMEI YIXING DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009
Table 3.64 BEIJING GOLDEN ELEPHANT DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009
Table 3.65 SHANGHAI YAOFANG CO., LTD.: FINANCIAL RESULTS, 2003-2009
Table 3.66 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.67 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009*
3.13 Shanghai No.1 Pharmacy Co., Ltd.
3.13.1 Shanghai No.1 Pharmacy: Company Details
3.13.2 Shanghai No.1 Pharmacy: Company Background
Table 3.68 SHANGHAI NO.1 PHARMACY CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2002-2009
Table 3.69 SHANGHAI NO.1 PHARMACY CO., LTD.: REVENUE OF KEY SUBSIDIARIES, 2007-2009
3.13.3 Shanghai No.1 Pharmacy: Financial Results
Table 3.70 SHANGHAI NO.1 PHARMACY CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.71 SHANGHAI NO.1 PHARMACY CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009*
3.14 Shanghai Pharmaceutical Holding Co., Ltd.
3.14.1 Shanghai Pharmaceutical Holding: Company Details
3.14.2 Shanghai Pharmaceutical Holding: Company Background
Table 3.72 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2009*
Table 3.73 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: PHARMACY DISTRIBUTION, 2009*
Table 3.74 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: REVENUE OF KEY SUBSIDIARIES & INVESTED FIRMS, 2009
Table 3.75 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: REVENUE OF OTHER INVESTED PHARMACY RETAILERS, 2009
3.14.3 Shanghai Pharmaceutical Holding: Financial Results
Table 3.76 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: FINANCIAL RESULTS, 2008-2009*
3.15 Sinopharm Holding Co., Ltd.
3.15.1 Sinopharm Holding: Company Details
3.15.2 Sinopharm Holding: Company Background
Table 3.77 SINOPHARM HOLDING CO., LTD.: RETAIL NETWORK, 2006-MAY 2009
Table 3.78 SINOPHARM HOLDING CO., LTD.: DETAILS ON RETAIL PHARMACY OPENING, CLOSURE & ACQUISITION, 2006-MAY 2009
Table 3.79 SINOPHARM HOLDING CO., LTD.: REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2006-2009
Table 3.80 SINOPHARM HOLDING GUODA DRUG STORE CO., LTD.: RETAIL NETWORK, 2006- 2009
Table 3.81 SINOPHARM HOLDING CO., LTD.: PRINCIPAL SUBSIDIARIES & ASSOCIATES, 2009
3.15.3 Sinopharm Holding: Financial Results
Table 3.82 SINOPHARM HOLDING GUODA DRUG STORE CO., LTD.: FINANCIAL RESULTS, 2006- 2009
Table 3.83 SHENZHEN ACCORD PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS (PHARMACEUTICAL RETAILING SEGMENT), 2006- 2009*
Table 3.84 SINOPHARM HOLDING CO., LTD.: FINANCIAL RESULTS, 2006-2009*
Table 3.85 SINOPHARM HOLDING CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009*
4 CONTACTS
4.1 Trade Organisations
China Pharmaceutical Enterprises Association
China Nonprescription Medicines Association
China Chamber of Commerce for Import & Export of Medicines & Health Products
China Health Care Association
China Association of Pharmaceutical Commerce
5 RELEVANT TRADE FAIRS & EXHIBITIONS
5.1 Trade Fairs & Exhibitions
China Drugstore Show
China International Medicinal Equipment Fair
China International Pharmaceutical Industry Exhibition
China International Pharmaceutical Ingredients Fair
China National Pharmaceuticals Fair (Pharm China)
Personal Care & Homecare Ingredients
CPhI China
APPENDIX: MARKET BACKGROUND
A.1 Fast Facts
A.2 Population
A.2.1 Population: By Age Group & Gender
Table A.1 POPULATION BY AGE GROUP & GENDER, 2003¨C2009*
A.2.2 Population: By Province
Table A.2 POPULATION BY PROVINCE, 2003¨C2009*
A.3 Exchange Rates
A.3.1 Exchange Rates: China
Table A.3 AVERAGE ANNUAL RENMINBI EXCHANGE RATES AGAINST A VARIETY OF CURRENCIES, 2002¨C2009
A.3.2 Exchange Rates: Hong Kong
Table A.4 AVERAGE ANNUAL HONG KONG DOLLAR EXCHANGE RATES AGAINST THE UNITED STATES DOLLAR AND RENMINBI, 2002¨C2009

More China Drug Stores reports

Health & beauty retailing – China – a snapshot (2012) by International Business Strategies
Health & beauty retailing in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This ...
Drug Stores and Health and Beauty Stores in BRIC: Market Guide to 2016 by Canadean Ltd
Synopsis Drug Stores and Health and Beauty Stores in BRIC: Market Guide to 2016 provides in-depth detail on the trends and drivers of the Drug Stores ...
Drug Stores and Health and Beauty Stores in BRIC: Market Snapshot to 2016 by Canadean Ltd
Synopsis Canadean’s, Drug Stores and Health and Beauty Stores in BRIC: Market Snapshot to 2016 contains detailed historic and forecast retail sales values of Drug Stores ...
Drug Stores and Health and Beauty Stores in China: Market Snapshot to 2016 by Canadean Ltd
Synopsis Canadean’s, Drug Stores and Health and Beauty Stores in China: Market Snapshot to 2016 contains detailed historic and forecast retail sales values of Drug Stores ...
See all reports like this >>

More China reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Related Markets


Drug Stores Reports

 
 

Share this report


Other tasks

 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!